GlaxoSmithKline, the pharmaceutical manufacturer that’s been making news about its controversial diabetes drug Avandia, has settled close to 200 Paxil lawsuits related to birth injuries.
GSK settled the cases after a Pennsylvania jury awarded a woman $2.5 million for failing to warn expectant mothers about the potential Paxil dangers such as birth defects including persistent pulmonary hypertension in babies and holes in the heart muscles.
While GSK has settled nearly 200 Paxil birth defect cases, there were 600 pending Paxil lawsuits pending prior to the announcement of the June settlement.
The pharmaceutical company has taken a $2.4 billion legal charge in order to settle the Paxil and Avandia lawsuits.
- 1 in 20 Patients Harmed by Medical Errors, New Report Finds - August 1, 2019
- Errors in Electronic Health Records: A Growing Source forMedical Malpractice Claims - May 23, 2018
- User and System Failures: The Problems with Electronic Health Records - January 29, 2018